Stay updated on ATH-1017 Study in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ATH-1017 Study in Alzheimer's Clinical Trial page.

Latest updates to the ATH-1017 Study in Alzheimer's Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide government funding/operational status notice and updated the page revision to v3.4.1 while removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' toggle and updated revision-related items, including 'Last Update Submitted that Met QC Criteria' and the 'Revision: v3.4.0' label, plus capitalization changes to 'No FEAR Act Data'. These changes are formatting and metadata updates rather than substantive content changes.SummaryDifference0.2%

- Check42 days agoChange DetectedSite revision updated to v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section reorganized to consolidate site locations under a single header, listing US states (California, Florida, Georgia, New York, Oregon, Washington) and Australian regions (New South Wales, Victoria, Western Australia); separate 'State Locations' headers were removed.SummaryDifference1%

- Check92 days agoChange DetectedThe site revision updated from v3.2.0 to v3.3.2, a routine version update reflected in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ATH-1017 Study in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATH-1017 Study in Alzheimer's Clinical Trial page.